258 related articles for article (PubMed ID: 33836561)
1. Type I interferon activation and endothelial dysfunction in caveolin-1 insufficiency-associated pulmonary arterial hypertension.
Gairhe S; Awad KS; Dougherty EJ; Ferreyra GA; Wang S; Yu ZX; Takeda K; Demirkale CY; Torabi-Parizi P; Austin ED; Elinoff JM; Danner RL
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836561
[TBL] [Abstract][Full Text] [Related]
2. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
[TBL] [Abstract][Full Text] [Related]
3. The Cavin-1/Caveolin-1 interaction attenuates BMP/Smad signaling in pulmonary hypertension by interfering with BMPR2/Caveolin-1 binding.
Tomita S; Nakanishi N; Ogata T; Higuchi Y; Sakamoto A; Tsuji Y; Suga T; Matoba S
Commun Biol; 2024 Jan; 7(1):40. PubMed ID: 38182755
[TBL] [Abstract][Full Text] [Related]
4. Role of G(i/o)-Src kinase-PI3K/Akt pathway and caveolin-1 in β₂-adrenoceptor coupling to endothelial NO synthase in mouse pulmonary artery.
Banquet S; Delannoy E; Agouni A; Dessy C; Lacomme S; Hubert F; Richard V; Muller B; Leblais V
Cell Signal; 2011 Jul; 23(7):1136-43. PubMed ID: 21385608
[TBL] [Abstract][Full Text] [Related]
5. BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension.
Awad KS; Wang S; Dougherty EJ; Keshavarz A; Demirkale CY; Yu ZX; Miller L; Elinoff JM; Danner RL
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791441
[TBL] [Abstract][Full Text] [Related]
6. Dissecting Molecular Mechanisms Underlying Pulmonary Vascular Smooth Muscle Cell Dedifferentiation in Pulmonary Hypertension: Role of Mutated Caveolin-1 (Cav1
Yu W; Chen H; Yang H; Ding J; Xia P; Mei X; Wang L; Chen S; Zou C; Wang LX
Heart Lung Circ; 2019 Oct; 28(10):1587-1597. PubMed ID: 30262154
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and DKK1-induced AKT activation contribute to endothelial dysfunction following NR2F2 loss.
Dougherty EJ; Chen LY; Awad KS; Ferreyra GA; Demirkale CY; Keshavarz A; Gairhe S; Johnston KA; Hicks ME; Sandler AB; Curran CS; Krack JM; Ding Y; Suffredini AF; Solomon MA; Elinoff JM; Danner RL
Am J Physiol Lung Cell Mol Physiol; 2023 Jun; 324(6):L783-L798. PubMed ID: 37039367
[TBL] [Abstract][Full Text] [Related]
8. miR‑371b‑5p inhibits endothelial cell apoptosis in monocrotaline‑induced pulmonary arterial hypertension via PTEN/PI3K/Akt signaling pathways.
Zhu G; Zhang W; Liu Y; Wang S
Mol Med Rep; 2018 Dec; 18(6):5489-5501. PubMed ID: 30387816
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of common signal transduction pathways affected by rBMSCs/F92A-Cav1 in the lungs of rat with pulmonary arterial hypertension.
Chen H; Yang H; Xu C; Yue H; Xia P; Strappe PM; Wang L; Pan L; Tang W; Chen S; Wang L
Biomed Pharmacother; 2016 Oct; 83():100-106. PubMed ID: 27470556
[TBL] [Abstract][Full Text] [Related]
10. Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1.
Bauer PM; Bauer EM; Rogers NM; Yao M; Feijoo-Cuaresma M; Pilewski JM; Champion HC; Zuckerbraun BS; Calzada MJ; Isenberg JS
Cardiovasc Res; 2012 Mar; 93(4):682-93. PubMed ID: 22215724
[TBL] [Abstract][Full Text] [Related]
11. Increased pulmonary vascular resistance and defective pulmonary artery filling in caveolin-1-/- mice.
Maniatis NA; Shinin V; Schraufnagel DE; Okada S; Vogel SM; Malik AB; Minshall RD
Am J Physiol Lung Cell Mol Physiol; 2008 May; 294(5):L865-73. PubMed ID: 18192592
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of angiotensin I-converting enzyme in caveolin-1 knockout mouse lungs.
Maniatis NA; Balyasnikova IV; Metzger R; Castellon M; Visintine DJ; Schwartz DE; Minshall RD; Danilov SM
Microvasc Res; 2010 Sep; 80(2):250-7. PubMed ID: 20430040
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cells Expressing eNOS and a Cav1 Mutant Inhibit Vascular Smooth Muscle Cell Proliferation in a Rat Model of Pulmonary Hypertension.
Chen H; Yang H; Yue H; Strappe PM; Xia P; Pan L; Zhang Y; Chai S; Chen S; Ma L; Wang L
Heart Lung Circ; 2017 May; 26(5):509-518. PubMed ID: 27771236
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
Li H; Lu W; Cai WW; Wang PJ; Zhang N; Yu CP; Wang DL; Liu BC; Sun W
Pulm Pharmacol Ther; 2014 Jun; 28(1):17-24. PubMed ID: 24269521
[TBL] [Abstract][Full Text] [Related]
15. In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug.
Hopper RK; Moonen JR; Diebold I; Cao A; Rhodes CJ; Tojais NF; Hennigs JK; Gu M; Wang L; Rabinovitch M
Circulation; 2016 May; 133(18):1783-94. PubMed ID: 27045138
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
Li G; Zhang H; Zhao L; Zhang Y; Yan D; Liu Y
J Am Soc Hypertens; 2017 Dec; 11(12):842-852. PubMed ID: 29146157
[TBL] [Abstract][Full Text] [Related]
17. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration.
Zhao YY; Zhao YD; Mirza MK; Huang JH; Potula HH; Vogel SM; Brovkovych V; Yuan JX; Wharton J; Malik AB
J Clin Invest; 2009 Jul; 119(7):2009-18. PubMed ID: 19487814
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3.
Huang A; Zhang YY; Chen K; Hatakeyama K; Keaney JF
Circ Res; 2005 Feb; 96(2):164-71. PubMed ID: 15604419
[TBL] [Abstract][Full Text] [Related]
19. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.
Awad KS; Elinoff JM; Wang S; Gairhe S; Ferreyra GA; Cai R; Sun J; Solomon MA; Danner RL
Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(2):L187-201. PubMed ID: 26589479
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the involvement of type I interferon in pulmonary arterial hypertension.
George PM; Oliver E; Dorfmuller P; Dubois OD; Reed DM; Kirkby NS; Mohamed NA; Perros F; Antigny F; Fadel E; Schreiber BE; Holmes AM; Southwood M; Hagan G; Wort SJ; Bartlett N; Morrell NW; Coghlan JG; Humbert M; Zhao L; Mitchell JA
Circ Res; 2014 Feb; 114(4):677-88. PubMed ID: 24334027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
